The risk is extremely low. Amniotic membrane tissue possesses a unique ****immune-privileged** characteristic, meaning it is unlikely to trigger an immune rejection response in the human body (which is why the fetus is not rejected in the womb). Furthermore, amniotic membrane preparations used in reputable medical institutions (such as Amniofix®) are derived from healthy donors delivered via cesarean section and undergo rigorous screening and patented aseptic processes in accordance with US FDA and AATB (American Association of Tissue Banks) standards, ensuring their safety has been widely validated internationally.
